171 related articles for article (PubMed ID: 24388410)
1. Vaccination against tumour blood vessels in colorectal cancer.
Ferguson HJ; Wragg J; Ismail T; Bicknell R
Eur J Surg Oncol; 2014 Feb; 40(2):133-6. PubMed ID: 24388410
[No Abstract] [Full Text] [Related]
2. Monoclonal antibodies in the treatment of advanced colorectal cancer.
Capdevila J; Saura C; Macarulla T; Casado E; Ramos FJ; Tabernero J
Eur J Surg Oncol; 2007 Dec; 33 Suppl 2():S24-34. PubMed ID: 17981431
[TBL] [Abstract][Full Text] [Related]
3. Bevacizumab.
Ellis LM
Nat Rev Drug Discov; 2005 May; Suppl():S8-9. PubMed ID: 15962523
[TBL] [Abstract][Full Text] [Related]
4. [Use of antibodies for colorectal cancer chemotherapy].
Kanemitsu K; Kakeji Y
Nihon Rinsho; 2014 Jan; 72(1):114-9. PubMed ID: 24597358
[TBL] [Abstract][Full Text] [Related]
5. [Monoclonal antibodies therapies for colorectal cancer: cétuximab, panitumumab and bevacizumab].
Piront P; Van Daele D; Belaiche J; Polus M
Rev Med Liege; 2009; 64(5-6):274-8. PubMed ID: 19642458
[TBL] [Abstract][Full Text] [Related]
6. [The cost study of first- line treatment of metastatic colorectal carcinoma with bevacizumab- containing regimen in the Czech Republic].
Hradecká I; Ríhová B; Horová R; Demlová R
Klin Onkol; 2014; 27(4):255-60. PubMed ID: 25115714
[TBL] [Abstract][Full Text] [Related]
7. [Molecular target therapy and chemotherapy for advanced colorectal cancer].
Nakashima K; Yamazaki K; Boku N
Gan To Kagaku Ryoho; 2008 May; 35(5):725-30. PubMed ID: 18487907
[TBL] [Abstract][Full Text] [Related]
8. Emerging therapies for metastatic colorectal cancer: focus on EGFR and VEGF inhibition.
Venook AP
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S74-84. PubMed ID: 19780248
[TBL] [Abstract][Full Text] [Related]
9. Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer?
Derangère V; Fumet JD; Boidot R; Bengrine L; Limagne E; Chevriaux A; Vincent J; Ladoire S; Apetoh L; Rébé C; Ghiringhelli F
Oncotarget; 2016 Feb; 7(8):9309-21. PubMed ID: 26824184
[TBL] [Abstract][Full Text] [Related]
10. Biological therapy update in colorectal cancer.
Sorscher SM
Expert Opin Biol Ther; 2007 Apr; 7(4):509-19. PubMed ID: 17373902
[TBL] [Abstract][Full Text] [Related]
11. [Antibody treatment in colorectal cancer--what the surgeon needs to know].
Thalheimer A; Illert B; Reimer P; Bueter M; Thiede A; Gasser M; Fein M; Waaga-Gasser AM; Meyer D
Zentralbl Chir; 2008 Apr; 133(2):101-6. PubMed ID: 18415895
[TBL] [Abstract][Full Text] [Related]
12. NICE guidance on cetuximab, bevacizumab, and panitumumab for treatment of metastatic colorectal cancer after first-line chemotherapy.
Rinaldi F; George E; Adler AI
Lancet Oncol; 2012 Mar; 13(3):233-4. PubMed ID: 22489288
[No Abstract] [Full Text] [Related]
13. [Treatment of colorectal cancer: present advances].
Goldwasser F
Presse Med; 2012 Jan; 41(1):44-5. PubMed ID: 22138291
[No Abstract] [Full Text] [Related]
14. Safety of bevacizumab with fluoropyrimidine-based regimens for first-line treatment of metastatic colorectal cancer.
Tyagi P
Clin Colorectal Cancer; 2006 Sep; 6(3):189-91. PubMed ID: 17026787
[No Abstract] [Full Text] [Related]
15. Antiangiogenesis drug promising for metastatic colorectal cancer.
McCarthy M
Lancet; 2003 Jun; 361(9373):1959. PubMed ID: 12801743
[No Abstract] [Full Text] [Related]
16. [A perspective: role of targeted therapy in colon cancer].
Chung HH; Jang BI
Korean J Gastroenterol; 2013 Mar; 61(3):128-35. PubMed ID: 23575231
[TBL] [Abstract][Full Text] [Related]
17. A review and assessment of currently available data of the EGFR antibodies in elderly patients with metastatic colorectal cancer.
Rosati G; Aprile G; Cardellino GG; Avallone A
J Geriatr Oncol; 2016 Mar; 7(2):134-41. PubMed ID: 26897044
[TBL] [Abstract][Full Text] [Related]
18. Integration of novel agents in the treatment of colorectal cancer.
Iqbal S; Lenz HJ
Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S32-9. PubMed ID: 15309512
[TBL] [Abstract][Full Text] [Related]
19. [Bevacizumab: progress in the treatment of metastatic cancer and hope for patients with proliferative retinopathy].
Antoniak K; Nowak JZ
Postepy Hig Med Dosw (Online); 2007 May; 61():320-30. PubMed ID: 17554235
[TBL] [Abstract][Full Text] [Related]
20. Promising early results for immunotherapy-antiangiogenesis combination.
Garber K
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25421345
[No Abstract] [Full Text] [Related]
[Next] [New Search]
